代表性成果 （論文/專利/專著等） |
代表性論文 1. Gao Y, He S, Meng X, …, Cui Y*, Zhang L*. Multi-omics analysis reveals immunosuppression in oesophageal squamous cell carcinoma induced by creatine accumulation and HK3 deficiency. Genome Med. 2025 May 6;17(1):44. (中科院TOP1區, IF=11.2) 2. Feng X, Chen J, Lian J, …, Cui Y*, Zhang L*. The glycogene alterations and potential effects in esophageal squamous cell carcinoma. Cell Mol Life Sci. 2024, 81(1):481. 2. 3. Guo Y, Wang X, Du Y, …, Xi Y*, Zhang L*. The splicing factor SF3B1 confers ferroptosis resistance and promotes lung adenocarcinoma progression via upregulation of SLC7A11. Cancer Gene Ther. 2024,31(10):1498-1510. 4. Yang X, Jiao Y, Zhang Y, …, Zhang L*, Kong P*. Oseltamivir enhances 5-FU sensitivity in esophageal squamous carcinoma with high SPNS1. Biomed Pharmacother. 2024 ,173:116367. 5. Feng X, Gao L, Shen X, …, Guo Y*, Zhang L*. A pan-cancer analysis of prognostic significance and immunological role of lysosomal-associated membrane protein 3. J Cell Mol Med. 2024, 28(3): e18088. 6. Ren J, Kong P, Wang Y, Guo D, Zhang L*. Copy number variations in esophageal squamous cell carcinoma: Emerging cancer drivers and biomarkers. Oncol Rep. 2024, 51(1): 8. 7. Guo Y, Hao Y, Shen L, …, Yang B*, Zhang L*. TSTA3 overexpression promotes malignant characteristics in LUSC by regulating LAMP2-mediated autophagy and tumor microenvironment. Cancer Cell Int. 2023, 23(1):285. 8. Gao Y, Shen L, Dong T, …, Zhang L*, Cui Y*. An N-glycoproteomic site-mapping analysis reveals glycoprotein alterations in esophageal squamous cell carcinoma. J Transl Med. 2022, 20(1):285. 9. Zhang L, Zhang J, Li S, …, Liu J*. Genomic amplification of long noncoding RNA HOTAIRM1 drives anaplastic thyroid cancer progression via repressing miR-144 biogenesis. RNA Biol. 2021, 18(4):547-562. 10. Zhang L, Gao Y, Zhang X, …, Cheng X,* Cui Y*. TSTA3 facilitates esophageal squamous cell carcinoma progression through regulating fucosylation of LAMP2 and ERBB2. Theranostics. 2020, 10(24):11339-11358. (中科院TOP1區, IF=13.3) 11. Zhang L, Niu X, Bi Y, …, Cheng X*. Potential Role of Targeting KDR and Proteasome Inhibitors in the Therapy of Esophageal Squamous Cell Carcinoma. Technol Cancer Res Treat. 2020, 19:1533033820948060. 12. Zhang L, Zhang X, Zhang H, …, Liu J.* Knockdown of SF3B1 Inhibits Cell Proliferation, Invasion and Migration Triggering Apoptosis in Breast Cancer via Aberrant Splicing. Breast Cancer. 2020, 27(3):464-476. 13. Zhang L, Zhou Y, Cheng C, …, Zhan Q*, Cui Y*. Genomic analyses reveal mutational signatures and frequently altered genes in esophageal squamous cell carcinoma. Am J Hum Genet, 2015, 96(4):597-611. (中科院TOP1區, IF=10.9) 14. Zhang L, Shi R, He C, Cheng C, …, Cui Y*. Oncogenic B-Raf(V600E) abrogates the AKT/B-Raf/Mps1 interaction in melanoma cells. Cancer Lett, 2013, 337(1):125-132. (中科院TOP1區, IF=10.1) 專利 1. TSTA3與LAMP2作為靶標物在食管鱗癌細胞轉移檢測、藥物篩選中的應用，ZL 2020 1 0797744.6，第一發明人 2. 一種消毒棉簽，ZL 2019 2 1930098.5號，第一發明人 3. 一種注射器用遮光套，ZL 2019 2 1577077.X號，第一發明人 4. 細胞密度控制儀及其方法、應用，ZL 2018 1 0424968.5，第十發明人 5. POFUT1 作為食管鱗癌診斷標志物、藥物篩選及預后評價試劑中的應用，2023110282554，第一發明人 |
